يعرض 261 - 280 نتائج من 23,970 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant ((teer decrease) OR (linear increased)) ))', وقت الاستعلام: 0.53s تنقيح النتائج
  1. 261

    DDC for four anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

    منشور في 2025
    الموضوعات:
  2. 262

    NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission. حسب Jinwei Zhang (462455)

    منشور في 2025
    "…The inhibitory synaptic density of NgR1 mice showed a significant decrease when compared to WT mice (***P <  0.001). …"
  3. 263
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268
  9. 269

    Boxplot mean cfPWV comparisons. حسب Johannes Nairz (18010746)

    منشور في 2024
    الموضوعات:
  10. 270

    Study flow chart. حسب Johannes Nairz (18010746)

    منشور في 2024
    الموضوعات:
  11. 271

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  12. 272
  13. 273
  14. 274

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  15. 275

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  16. 276
  17. 277
  18. 278
  19. 279
  20. 280